Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

Kremer, I.E.
Evers, S.M.
Jongen, P.J.
Weijden, T.T. van der
Kolk, I. van de
Hiligsmann, M.J.C.

January 2016

Contains fulltext : 172725.PDF (publisher's version ) (Open Access)OBJECTIVES: Und...

Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment

Garcia-Dominguez JM
Muñoz D
Comellas M
Gozalbo I
Lizán L
Polanco Sánchez C

September 2016

José Manuel Garcia-Dominguez,1 Delicias Muñoz,2 Marta Comellas,3 Irmina Gonzalbo,3 Lui...

Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational study

Arroyo, Rafael
Perez-Sempere, Angel
Ruiz-Beato, Elena
Prefasi, Daniel
Carreño, Agata
Roset, Montse
Maurino, Jorge

March 2017

Objective: To assess patients' preferences for a range of disease-modifying therapy (DMT) attributes...

Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study

Poulos, Christine
Wakeford, Craig
Kinter, Elizabeth
Mange, Brennan
Schenk, Thomas
Jhaveri, Mehul

January 2020

Objective: To assess heterogeneity in patient and physician preferences for multiple sclerosis treat...

Patient Preferences for Attributes of Disease-Modifying Multiple Sclerosis Therapies: Development and Results of a Ratings-Based Conjoint Analysis

Wilson, Leslie S
Loucks, Aimee
Gipson, Gregory
Zhong, Lixian
Bui, Christine
Miller, Elizabeth
Owen, Mary
Pelletier, Daniel
Goodin, Douglas
Waubant, Emmanuelle
McCulloch, Charles E

March 2015

BackgroundTimely individualized treatment is essential to improving relapsing-remitting multiple scl...

Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

Kremer, I.E.
Evers, S.M.
Jongen, P.J.
Weijden, T.T. van der
Kolk, I. van de
Hiligsmann, M.J.C.

January 2016

Contains fulltext : 172725.PDF (publisher's version ) (Open Access)OBJECTIVES: Und...

Patient Preferences for Attributes of Disease-Modifying Multiple Sclerosis Therapies: Development and Results of a Ratings-Based Conjoint Analysis

Wilson, Leslie S
Loucks, Aimee
Gipson, Gregory
Zhong, Lixian
Bui, Christine
Miller, Elizabeth
Owen, Mary
Pelletier, Daniel
Goodin, Douglas
Waubant, Emmanuelle
McCulloch, Charles E

March 2015

BackgroundTimely individualized treatment is essential to improving relapsing-remitting multiple scl...

Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

Kremer, I.E.
Evers, S.M.
Jongen, P.J.
Weijden, T.T. van der
Kolk, I. van de
Hiligsmann, M.J.C.

January 2016

Contains fulltext : 172725.PDF (publisher's version ) (Open Access)OBJECTIVES: Und...